Madrigal Pharmaceuticals Inc (MDGL)

Total Costs & Expenses

$420.56M

Quarterly · Period ending: · USD

MDGL logo

MDGL Total Costs & Expenses

Latest reported$420.56M
MDGL Quarterly Total Costs & Expenses ($9.14M → $420.56M)
High-resolution chart · PNG

MDGL total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Madrigal Pharmaceuticals Inc Total Costs & Expenses — Quarterly (USD)
Period endingTotal Costs & Expenses (USD)
420,560,000
404,060,000
380,692,000
401,243,000
260,004,000
216,561,000
170,316,000
178,479,000
177,175,000
152,037,000
117,176,000
98,534,000
86,450,000
78,336,000
85,299,000
80,412,000
70,273,000
57,587,000
64,601,000
63,160,000
61,742,000
52,979,000
59,555,000
58,786,000
50,327,000
38,005,000
29,954,000
24,195,000
22,704,000
18,119,000
14,454,000
11,333,000
7,826,000
7,069,000
8,911,000
8,637,000
8,439,000
6,075,000
7,756,000
14,091,000
3,489,000
6,447,000
10,380,000
17,394,000
19,504,000
20,332,000
19,894,000
19,449,000
21,701,000
22,907,000
23,444,000
21,794,000
22,063,000
20,258,000
17,703,000
14,539,000
14,134,000
14,712,000
13,662,000
13,882,000
13,363,000
12,109,000
12,402,000
13,614,000
12,404,000
13,281,000
11,660,000
12,233,000
13,103,000
26,709,000
26,501,000
27,723,000
24,285,000
19,783,000
17,086,000
15,394,000
17,466,000
17,012,000
13,005,000
14,577,000
-14,928,000
-14,928,000
-15,492,000
-26,686,000
-26,686,000
18,498,000
9,142,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.